This interactive educational event is designed to help haematology trainees prepare effectively for the end of training and the European Haematology examinations. Participants will have the opportunity to assess their knowledge against the European Haematology Curriculum, identify learning needs, and strengthen their understanding of key topics. Through case-based discussions and interactive sessions, delegates will develop a structured approach to managing complex clinical cases while gaining practical insights from experienced national and international faculty. The event also provides a valuable platform for networking, enabling trainees to connect with peers and colleagues from across the haematology community and share experiences.

TOPICS COVERED

During this interactive workshop, participants will complete progress test assessments to evaluate their knowledge and identify areas for further development. They will review their results in facilitated feedback sessions, discussing key learning points, exam techniques, and approaches to answering questions effectively.
Attendees will also take part in a morphology examination session, working through cases to strengthen their diagnostic skills and exam readiness. Throughout the day, participants will engage with expert faculty and peers, share experiences, discuss challenging topics, and gain practical insights to support their preparation for the European Haematology examinations.

WHO SHOULD ATTEND?

The workshop is primarily aimed at haematology registrars/trainees who are approaching the end of specialty training and preparing for final training examinations, including the EHA Exam and FRCPath Part 2. The sessions are designed to improve core knowledge and lymphoid and myeloid disorders while also enhancing clinical knowledge and decision-making skills in myeloid and lymphoid disorders.
Please note: You do not need to be an EHA member to attend. If you are not already registered with EHA, you can create a free EHA account to access the registration page.

SPEAKERS

• Dr Mahesh Prahladan, will present at most sessions.
• Dr Jyothi Nangalia (Wellcome Sanger Institute and Cambridge Stem Cell Institute) will present the scientific journey behind the discovery of CALR mutations and discuss the profound impact this landmark finding has had on our understanding, diagnosis, and management of myeloproliferative neoplasms.

For more information, please contact: [email protected].